CVE-2026-18221Patch(ibm / i)

LOWCVSS 9.8 · CRITICAL

Signal is active with 1 mentions in latest observed window

Immediate actions

  • Patch ibm i systems immediately

Recommended action window: Monitor and triage in normal cycle

NVD description

IBM i 7.6, 7.5, 7.4, and 7.3 could allow a remote attacker to gain unauthorized access due to improper validation of client-supplied authentication parameters.

0.5/ 10 priority

Sources & remediation

Weakness type (CWE)
CWE-287

Priority

LOW

Exploitation

NONE

PoC

NONE

Patch

AVAILABLE

Momentum

NONE

Are you affected?

If you run products in this scope, you should treat this CVE as relevant to your environment.

  • i

Threat summary

  • Patch or workaround signal is available
  • 1 mentions across 1 observed day

What's happening

  • Patch or workaround mentioned in 1 signal
  • Technical details provided in 1 signal
  • 1 total mentions across 1 day

Affected systems

Vendors
Products
i

4 versions affected across 1 product

Deep dive

Activity timeline1 mentions / 1d
00111Mentions · 2026-09-07: 1Patch / Workaround · 2026-09-07: 1Technical Details · 2026-09-07: 109-07
Signal classification1 categories
Patch
1100.0%
Full discourse1 post
  • CCB Alert@CCBalert
    Patch

    Warning: High severity vulnerabilities in IBM i DDM/DRDA. CVE-2026-18175 & CVE-2026-18221 CVSS: 8.1. Improper authorization & authentication flaws let remote attackers manipulate database transactions or gain unauthorized access. #Patch #Patch #Patch

    Post summary

    IBM i DDM/DRDA has two high‑severity vulnerabilities (CVE‑2026‑18175 & CVE‑2026‑18221) that let remote attackers bypass authentication and manipulate database transactions; patches are strongly recommended.

    11010278
    7.2K followersView on X
CPE platform detail4 entries

4 of 4 entries

PartVendorProductVersionTarget SWTarget HW
OSibmi7.3--
OSibmi7.4--
OSibmi7.5--
OSibmi7.6--

Explore more